uterine leiomyomata به نام یگانه هستی بخش uterine leiomyomata dr_firouzabadi...
TRANSCRIPT
![Page 1: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/1.jpg)
به نام یگانه هستی بخش
Uterine LeiomyomataUterine Leiomyomata
DR_FIROUZABADIDR_FIROUZABADI
![Page 2: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/2.jpg)
commonly termed fibroids
the most common benign tumors of the female genital tract and likely are the most common soft tissue tumors of all.
200,000 hysterectomies and 20,000 myomectomies annually in the United States.
50% of women having identifiable fibroids at menopause.
![Page 3: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/3.jpg)
Clinical Presentation
While fibroids can cause symptoms at any age after puberty, they typically do so in the early to mid 30s.
The symptoms caused by leiomyomata vary depending on the size, number, and location of the tumors.
![Page 4: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/4.jpg)
TABLE 55.1 Symptoms of Leiomyomata
* *Menorrhagia*Dysmenorrhea*Pelvic pressure (pressure on adjacent pelvic viscera) Urinary frequency Constipation Dyspareunia*Infertility*Repetitive pregnancy loss First trimester Second and third trimester (preterm labor)*Abdominal Distension
![Page 5: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/5.jpg)
oligomenorrhea, regardless of the amount, or metrorrhagia does not suggest fibroids but rather an underlying endocrine abnormality (e.g., anovulation).
Furthermore, the typical scenario
encountered with fibroids is not a sudden heavy bleeding episode but rather gradually increasing menstrual bleeding, paralleling tumor growth.
![Page 6: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/6.jpg)
Leiomyomata may undergo rapid enlargement during pregnancy, outstripping their blood supply and resulting in central avascular necrosis, the so-called red degeneration. The pain may be severe, requiring hospitalization and narcotics, but rarely puts a pregnancy at risk.
![Page 7: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/7.jpg)
Ph/E
![Page 8: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/8.jpg)
Anatomic Features
Leiomyomata are benign, sex steroid-responsive, smooth muscle tumors of the uterus originating as clonal expansions of individual myometrial cells.
The histology is virtually indistinguishable from normal myometrium except for a discrete circular whorling pattern with the cellularity and mitotic activity being highly variable.
![Page 9: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/9.jpg)
Leiomyosarcomas do not arise from preexisting leiomyomata and present much later in life, well after menopause.
![Page 10: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/10.jpg)
Types of leiomyoma
![Page 11: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/11.jpg)
There is virtually no neovascularity within fibroids
Collateral vascular channels are comparably maximally engorged and may represent a surgical challenge.
![Page 12: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/12.jpg)
Influence of Sex Steroids
There is little doubt that the growth of leiomyomata is dependent on sex steroids as they:
(a) are not noted prior to puberty.
(b) typically regress after menopause.
(c) possess sex steroid receptors (estrogen and progesterone).
![Page 13: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/13.jpg)
(d) often dramatically enlarge during pregnancy when estrogen and progesterone levels are very high.
(e) can be made to shrink with medically induced hypogonadism.
![Page 14: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/14.jpg)
myomatous tissue has the same number of estrogen receptors but a higher number of progesterone receptors than the adjacent normal myometrium.
![Page 15: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/15.jpg)
Situations that increase lifetime exposure to estrogen such as obesity and early menarche are associated with increased risk with the interval from the last delivery inversely related to risk.
![Page 16: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/16.jpg)
oral contraceptives
hormone replacement therapy
Tamoxifen
![Page 17: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/17.jpg)
Genetic Inheritance Pattern
more than 40% of first-degree female relatives of women with leiomyomata
common in all races, especially black women
the most frequent indication for gynecologic surgery.
multifactorial genetic inheritance pattern
![Page 18: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/18.jpg)
Molecular Mechanisms and Genetic Dysregulation monoclonal neoplasms
The most common aberrant patterns are translocations between chromosomes 12 and 14 (larger myomas), deletions of the short arm of chromosome 7 (smaller tumors), and rearrangements of the long arm of chromosome 6.
![Page 19: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/19.jpg)
Impact of Leiomyomata on Reproduction
TABLE 55.2 Mechanisms of Infertility with Leiomyomata
*Impaired implantation Submucous Intracavitary Enlarged uterine cavity volume*Impaired tubal transport Obstruction Distension
![Page 20: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/20.jpg)
Intramural leiomyomata and ART first-trimester pregnancy loss, preterm
labor, or intrauterine growth restriction
abruption placental classic cesarean delivery The need to perform a cesarean following
myomectomy needs to be considered in any risk-benefit analysis.
![Page 21: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/21.jpg)
Diagnostic StudiesThe majority of leiomyomata are detected on pelvic examination
performed because of gynecologic symptoms. The uterus is typically noted to be enlarged and irregular on bimanual examination.
It is important to distinguish leiomyomata from other pelvic masses, and it may be difficult to do so in the presence of a large uterus.
This is most easily done with an endovaginal or abdominal ultrasound scan, as the leiomyomata appear echogenic with similar acoustic impedance to the normal myometrium.
Computerized tomography and magnetic resonance imaging (MRI) may prove useful in selected circumstances , but they are much more expensive and yield little more useful information than office sonography.
![Page 22: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/22.jpg)
Diagnostic Imaging Techniques1.Endovaginal ultrasonography
2.Sonohysterography3.Hysterosalpingography4.Hysteroscopy5.Computerized tomography6.Magnetic resonance imaging
![Page 23: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/23.jpg)
Diagnostic Studies (cont’d)sonography:The proximity of the leiomyomata to the endometrial
cavity can usually be demonstrated by taking advantage of the acoustic differences between normal myometrium, fibroid tumors, and the endometrial cavity.
The endometrial stripe is a reliable marker of the endometrial cavity, and finding a smooth, continuous endometrial stripe with normal underlying myometrium between the cavity and any fibroids suggests that they are not submucosal.
![Page 24: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/24.jpg)
Diagnostic Studies (cont’d)Simultaneously injecting saline into the
endometrial cavity while performing an endovaginal ultrasound examination (sonohysterography) improves the ability to delineate submucous and intracavitary leiomyomata.
However, it is not possible to distinguish an endometrial polyp from an intracavitary myoma by virtually any imaging technique.
![Page 25: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/25.jpg)
Diagnostic Studies (cont’d)Hysterosalpingography is often undertaken if
infertility is present concurrently, as this technique can identify intracavitary tumors or a large but otherwise normal endometrial cavity caused by the stretching the normal myometrium around leiomyomata .
This radiographic technique has the added advantage of determining tubal patency as well.
![Page 26: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/26.jpg)
Diagnostic Studies (cont’d)Increasingly, office hysteroscopy is being
used when tubal patency is not an issue, as this technique allows clear differentiation between leiomyomata and other intracavitary pathology such as endometrial adhesions, uterine septae, and endometrial polyps.
![Page 27: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/27.jpg)
Diagnostic Studies (cont’d)Adenomyosis can occasionally be difficult to
distinguish clinically from leiomyomata.Imaging studies may not be helpful. The true diagnosis only made at surgery. MRI has been reported to be useful in
differentiating adenomyosis from leiomyomata.
![Page 28: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/28.jpg)
When to TreatDespite the fact that fibroids are responsible for a
large number of gynecologic surgeries, treating these benign tumors requires the same risk-benefit analysis as any other therapeutic decision.
Often, simply using a prostaglandin synthetase inhibitor or oral contraceptives will adequately relieve the symptoms.
![Page 29: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/29.jpg)
When to Treat (cont’d)It may be appropriate to remove asymptomatic,
extremely large leiomyomata in an effort to prevent anticipated reproductive problems.
Large tumors that fill the pelvis can impinge on the
pelvic sidewalls, causing hydronephrosis, and their removal is critical to prevent renal impairment.
![Page 30: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/30.jpg)
When to Treat (cont’d)The growth characteristics of individual fibroids remain
highly unpredictable. Many have limited growth potential.
Some leiomyoma have already experienced rapid growth and have undergone aseptic necrosis and replacement by fibrosis, so they have no further growth potential and will not regress after menopause.
Many fibroids may gradually enlarge and cause
symptoms well before the anticipated regression at menopause.
![Page 31: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/31.jpg)
When to Treat (cont’d)Gradually worsening dysmenorrhea and menorrhagia
are more frequently linked than other symptoms.
When these symptoms are mild, nonsteroidal anti-inflammatory agents and oral contraceptives are often useful.
![Page 32: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/32.jpg)
When to Treat (cont’d)Location of the fibroids is important with regard to the
development of symptoms: The closer the proximity to the endometrial cavity, the greater
and earlier the symptoms are observed. Intramural, submucosal, and intracavitary fibroids are far more
likely to be responsible for dysmenorrhea and menorrhagia than pedunculated or subserosal myomas. Severe symptoms may warrant intervention at a relatively small size, particularly when an intracavitary or submucosal fibroid is present.
Similarly, the closer to the serosal surface the fibroids are located, the larger the size will be attained before being detected. Indeed, some extremely large leiomyomata will not be associated with any symptoms aside from increased abdominal girth.
![Page 33: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/33.jpg)
When to Treat (cont’d)Because the bladder is adjacent to the uterus, the
most frequent symptom associated with a large myomatous uterus is increased urinary frequency.
Rarely, compression of the colon against the sacrum may cause difficulty with defecation; however, more often than not, complaints of constipation are not completely relieved by removing or shrinking the leiomyomata.
![Page 34: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/34.jpg)
Selecting the Appropriate TherapyWhen clear indications for treatment are
present, the most critical questions to ask before making a therapy decision pertain to (a) whether future reproduction is desired (b) how soon menopause can be anticipated.
![Page 35: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/35.jpg)
Selecting the Appropriate Therapy (cont’d)
As a simple hysterectomy represents a definitive cure, this is an attractive option for many symptomatic women when:
1. maintenance of reproduction is not desired, 2. menopause is not imminent,
3. and more conservative measures have failed to alleviate the symptoms .
![Page 36: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/36.jpg)
Selecting the Appropriate Therapy (cont’d)
When the preservation of future childbearing is desired, a myomectomy is the primary choice.
![Page 37: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/37.jpg)
Extirpative OptionsEndoscopic techniques
Laparoscopically assisted supracervical hysterectomy Laparoscopically assisted total hysterectomy Laparoscopic myomectomy Hysteroscopic resection of leiomyomataAbdominal approach Supracervical hysterectomy Total hysterectomy MyomectomyVaginal approach Hysterectomy Myomectomy
![Page 38: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/38.jpg)
HysterectomyWhen:
future childbearing is not desired,
the symptoms are severe enough to warrant treatment, and
the woman has no contraindications,
a simple hysterectomy is often chosen.
![Page 39: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/39.jpg)
Hysteroscopic MyomectomyMost intracavitary leiomyomata and a
substantial number of submucous leiomyomata can be resected via surgical hysteroscopy in an ambulatory setting.
![Page 40: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/40.jpg)
Abdominal MyomectomyWhen symptomatic leiomyomata are not
amenable to a hysteroscopic approach, an abdominal approach usually is required.
![Page 41: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/41.jpg)
Abdominal Myomectomy (cont’d)
An elective cesarean section is the preferred route of delivery for the vast majority of women with a previous abdominal myomectomy.
![Page 42: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/42.jpg)
Minimally Invasive MyomectomyPedunculated, serosal, and selected intramural
leiomyomas can be dissected free from the surrounding myometrium, morcellated, and the incision closed via laparoscopy.
![Page 43: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/43.jpg)
Recurrence of LeiomyomataSince there is a genetic basis for the
development of leiomyomata, even when all of the palpable leiomyomata have been surgically removed, the rate of recurrence and/or persistence with continued growth has been variably reported to be as high as 30% to 40%, depending on the:
Number of tumors removed
The length of follow-up.
![Page 44: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/44.jpg)
Recurrence of Leiomyomata (cont’d)Indeed, between 10% and 25% of women
undergoing myomectomies require another surgical procedure within the next decade.
![Page 45: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/45.jpg)
Recurrence of Leiomyomata (cont’d)Isolated large fibroids have lower recurrence
rates than when multiple small tumors are present, despite an overall smaller volume of leiomyomata .
![Page 46: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/46.jpg)
Postoperative Pelvic AdhesionsThe frequency of postoperative adhesions following
myomectomy exceeds 50% and can result in reduced fertility, pain, or bowel obstruction.
Careful surgical technique to minimize the degree of surgical trauma,
confining the incisions to the anterior uterine surface so as to prevent contact with the bowel and adnexal structures, and
covering the posterior uterine incisions with surgical barriers ,
have been advocated to minimize the rate of postoperative adhesions.
![Page 47: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/47.jpg)
Non-extirpative OptionsMyolysis
UAE MRI-guided HIFUMedically induced hypogonadism GnRH agonist GnRH agonist with “add-back” therapy
![Page 48: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/48.jpg)
Medical SuppressionMany medicinal agents have been considered
for the treatment of symptomatic leiomyomata, including:
1.estrogen antagonists,
2.progesterone antagonists (mifepristone), 3.androgens (danazol),
4.pituitary down-regulation with GnRH agonists.
![Page 49: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/49.jpg)
Medical Suppression (cont’d)Hypogonadism cannot be sustained for a
prolonged interval because of the significant side effects such as:
vasomotor hot flashes,
accelerated bone loss,
genital tract atrophy, and
loss of the cardiovascular protection.
![Page 50: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/50.jpg)
Medical Suppression (cont’d)The important question to ask is, “What is the
goal of medical suppression?”
Currently, the most relevant clinical use of GnRH agonists is to stop excessive vaginal bleeding and improve the hemogram prior to surgery or in order to delay surgery to correct other medical problems that are posing an increased surgical risk.
![Page 51: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/51.jpg)
MyolysisThere have been many attempts at inducing
therapeutic necrosis of cells within the center of a fibroid (e.g., myolysis), thereby shrinking the tumor size, relieving symptoms, and preventing progressive growth of the tumors.
![Page 52: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/52.jpg)
Myolysis (cont’d) The aseptic necrosis may cause significant
pain in the immediate post-treatment interval, comparable to that observed with degeneration of leiomyomata seen in pregnancy.
![Page 53: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/53.jpg)
Myolysis (cont’d)Myolysis should be confined to those women
who are not interested in subsequent pregnancy until well-designed, long-term comparative trials demonstrate safety.
![Page 54: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/54.jpg)
Uterine Artery EmbolizationWhen menorrhagia is the primary clinical
symptom and either the surgical risk is judged unacceptable or the patient declines extirpative surgery, therapeutic embolization of the uterine arteries can be utilized to reduce symptoms. This strategy is to simultaneously deprive the uterus and the fibroids of their blood supply, induce necrosis, and reduce the symptoms .
![Page 55: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/55.jpg)
UAE (cont’d)Since UAE has only been widely utilized for
only slightly over a decade, the long-term safety and efficacy remain to be demonstrated.
![Page 56: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/56.jpg)
![Page 57: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/57.jpg)
57
Adenomyosis
![Page 58: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/58.jpg)
58
Definition A benign uterine condition in which
endometrial glands and stroma are present within the uterine musculature
![Page 59: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/59.jpg)
59
Etiology The cause of adenomyosis is unknown uterine trauma
caesarean section tubal ligation pregnancy
Basal endometrial hyperplasia invading a hyperplastic myometrial stroma.
![Page 60: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/60.jpg)
Four primary theories
Heredity
Trauma
Hyperestrogenemia
Viral transmission
60
![Page 61: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/61.jpg)
61
![Page 62: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/62.jpg)
62
![Page 63: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/63.jpg)
63
![Page 64: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/64.jpg)
64
The thickened and spongy appearing myometrial wall of this sectioned uterus is typical of adenomyosis. There is also a small white leiomyoma at the lower left.
![Page 65: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/65.jpg)
Adenomyosis, Hysterectomy Specimen
65
![Page 66: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/66.jpg)
66
![Page 67: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/67.jpg)
Adenomyosis correlates with abnormal amounts of multiple substances, possibly indicating a causative link in its pathogenesis:
Endometrial IL-18 receptor mRNA and the ratio of IL-18 binding protein to IL-18 are significantly increased in adenomyosis patients in comparison to normal people
67
![Page 68: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/68.jpg)
68
Clinical features1 Asymptomatic
Classic symptoms: secondary dysmenorrhea abnormal uterine bleeding Chronic pelvic pain may occur
![Page 69: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/69.jpg)
69
Clinical features2: Most common physical sign
a diffusely enlarged uterus
particularly tender during
menstruation
![Page 70: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/70.jpg)
70
Diagnosis: History Pelvic examinations Ultrasonography MRI Serum markersCA-125 definitive diagnosis can only be made
from histological examination of a hysterectomy specimen
![Page 71: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/71.jpg)
71
Treatment Hormone therapy NSAIDs Hysterectomy the only uniformly
successful treatment for adenomyosis is necessary.
![Page 72: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/72.jpg)
Endometrial polyps
72
![Page 73: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/73.jpg)
Definition
Benign localised overgrowth of endometrial glands and stroma, covered by epithelium, projecting above the adjacent epithelium
73
![Page 74: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/74.jpg)
epidemiology 12-80 Years old Most occur in women in their 40s and 50s Endometrial polyps occur in up to 10% of
women It is estimated that they are present in 25% of
women with abnormal vaginal bleeding Large endometrial polyps can also be
associated with tamoxifen use(associated with a higher risk of neoplasia and different molecular alterations)
74
![Page 75: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/75.jpg)
Risk factors Risk factors include
• obesity• high blood pressure• history of cervical polyps• tamoxifen• hormone replacement therapy
75
![Page 76: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/76.jpg)
Pathological findings Sessile or pedunculated Size: 1mm and beyond – may fill the
endometrial cavity and project through the cervical os
red/brown color ,large ones can appear to be a darker red
May be multiple May originate anywhere, but most commonly
fundus
76
![Page 77: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/77.jpg)
etiology No definitive cause of endometrial polyps
is known
affected by hormone levels and grow in response to circulating estrogen
77
![Page 78: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/78.jpg)
78
![Page 79: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/79.jpg)
79
![Page 80: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/80.jpg)
80
![Page 81: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/81.jpg)
81
![Page 82: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/82.jpg)
symptoms
They often cause no symptoms Where they occur, symptoms include
"spotting" between menstrual periods, or after menopause
irregular menstrual bleeding bleeding between menstrual periods excessively heavy menstrual bleeding vaginal bleeding after menopause If the polyp protrudes through the cervix into the
vagina, pain (dysmenorrhea) may result82
![Page 83: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/83.jpg)
Diagnosis
vaginal ultrasound (sonohysterography)
hysteroscopy
dilation and curettage
83
![Page 84: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/84.jpg)
Treatment
IntraUterine System containing levonorgestrel in women taking Tamoxifen may reduce the incidence of polyps
Polyps can be surgically removed using curettage or hysterescopy
If it is a large polyp, it can be cut into sections before each section is removed
If cancerous cells are discovered, a hysterectomy may be performed
84
![Page 85: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/85.jpg)
85
![Page 86: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/86.jpg)
Prognosis and complications
Endometrial polyps are usually benign although some may be precancerous or cancerous
About 0.5% of endometrial polyps contain adenocarcinoma cells
Polyps can increase the risk of miscarriage in women undergoing IVF treatment
Although treatments such as hysterescopy usually cure the polyp concerned, recurrence of endometrial polyps is frequent
Untreated, small polyps may regress on their own
86
![Page 87: Uterine Leiomyomata به نام یگانه هستی بخش Uterine Leiomyomata DR_FIROUZABADI DR_FIROUZABADI](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649e845503460f94b8595e/html5/thumbnails/87.jpg)
87